HIV-1 infection in adults in combination with other antiretroviral drugs; HIV-1 infection in children 12 to 18 years of age with NRTI resistance or toxicity precluding the use of first-line antiretrovirals.
Chronic hepatitis B in adults.
Active ingredient: tenofovir 245
|Quantity of tablets||
up to 25 degrees
up to 2 kg $50